GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » Cash Receipts from Loans

CTOR (Citius Oncology) Cash Receipts from Loans


View and export this data going back to 2024. Start your Free Trial

What is Citius Oncology Cash Receipts from Loans?

Cash Receipts from Loans only applicable to companies reporting Cash Flow from Operations in direct method.


Citius Oncology Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
420 Lexington Ave, Suite 2446, New York, NY, USA, 10170
Website
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.